Market Research Logo

Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017

Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2017 provides an overview of Synthetic Bone Graft Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Synthetic Bone Graft Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.Scope

  • Extensive coverage of the Synthetic Bone Graft Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Synthetic Bone Graft Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Synthetic Bone Graft Substitutes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Synthetic Bone Graft Substitutes Overview
  • Products under Development
    • Synthetic Bone Graft Substitutes Pipeline Products by Stage of under Development
      • Table Figure 1: Synthetic Bone Graft Substitutes Pipeline Products by Stage of under Development
      • Table Synthetic Bone Graft Substitutes Pipeline Products by Stage of under Development
    • Synthetic Bone Graft Substitutes Pipeline Products by Territory
      • Table Figure 2: Synthetic Bone Graft Substitutes Pipeline Products by Territory
      • Table Synthetic Bone Graft Substitutes Pipeline Products by Territory
    • Synthetic Bone Graft Substitutes Pipeline Products by Regulatory Path
      • Table Figure 3: Synthetic Bone Graft Substitutes Pipeline Products by Regulatory Path
      • Table Synthetic Bone Graft Substitutes Pipeline Products by Regulatory Path
    • Synthetic Bone Graft Substitutes Pipeline Products by Estimated Approval Date
      • Table Figure 4: Synthetic Bone Graft Substitutes Pipeline Products by Estimated Approval Date
      • Table Synthetic Bone Graft Substitutes Pipeline Products by Estimated Approval Date
    • Synthetic Bone Graft Substitutes Ongoing Clinical Trials
      • Table Figure 5: Synthetic Bone Graft Substitutes Ongoing Clinical Trials
      • Table Synthetic Bone Graft Substitutes Ongoing Clinical Trials
  • Synthetic Bone Graft Substitutes Pipeline Products under Development by Companies
    • Synthetic Bone Graft Substitutes Companies Pipeline Products by Stage of Development
      • Table Synthetic Bone Graft Substitutes Companies Pipeline Products by Stage of Development
    • Synthetic Bone Graft Substitutes Pipeline Products by Stage of Development
      • Table Synthetic Bone Graft Substitutes Pipeline Products by Stage of Development
  • Synthetic Bone Graft Substitutes Companies and Product Overview
    • Advanced Biologics LLC Company Overview
      • Advanced Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Advanced Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table OsteoMEM Synthetic Bone Graft Substitute Product Status
        • Table OsteoMEM Synthetic Bone Graft Substitute Product Description
    • Aeon Astron Corporation Company Overview
      • Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioBone Filler Product Status
        • Table BioBone Filler Product Description
    • Agenta Biotechnologies Inc Company Overview
      • Agenta Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Agenta Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table B-247 Cranial Bone Graft Implant Product Status
        • Table B-247 Cranial Bone Graft Implant Product Description
    • Allegra Orthopaedics Ltd Company Overview
      • Allegra Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Allegra Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sr-HT-Gahnite Bone Substitute Product Status
        • Table Sr-HT-Gahnite Bone Substitute Product Description
    • Alphatec Holdings Inc Company Overview
      • Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bonex Product Status
        • Table Bonex Product Description
    • Amend Surgical, Inc. Company Overview
      • Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomimetic Bone Product Status
        • Table Biomimetic Bone Product Description
    • Anika Therapeutics Inc Company Overview
      • Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hyalobone Product Status
        • Table Hyalobone Product Description
    • Baxter International Inc Company Overview
      • Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Synthetic Bone Graft Orthopaedic Product Status
        • Table Synthetic Bone Graft Orthopaedic Product Description
        • Table Synthetic Bone Graft Spinal Product Status
        • Table Synthetic Bone Graft Spinal Product Description
    • Berkeley Advanced Biomaterials Inc Company Overview
      • Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CPA Ceramics Product Status
        • Table CPA Ceramics Product Description
        • Table HAP Ceramics Product Status
        • Table HAP Ceramics Product Description
    • Bio2 Technologies, Inc. Company Overview
      • Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hammertoe Intramedullary Fusion Device Product Status
        • Table Hammertoe Intramedullary Fusion Device Product Description
    • Bone Solutions Inc Company Overview
      • Bone Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bone Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Osteocrete Bone Anchor Product Status
        • Table Osteocrete Bone Anchor Product Description
        • Table OsteoCrete Cranial Product Status
        • Table OsteoCrete Cranial Product Description
        • Table OsteoCrete Maxillofacial Product Status
        • Table OsteoCrete Maxillofacial Product Description
        • Table OsteoCrete Non Load Bearing Spine Product Status
        • Table OsteoCrete Non Load Bearing Spine Product Description
    • BoneGrafix, Inc. Company Overview
      • BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Solid Bone Block Product Status
        • Table Solid Bone Block Product Description
    • BoneSupport AB Company Overview
      • BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cerament|G Product Status
        • Table Cerament|G Product Description
        • Table BoneSupport AB Ongoing Clinical Trials Overview
        • Table Cerament|G A Prospective, Randomized Multicenter Controlled Trial of CERAMENT|G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures
        • Table Cerament|G CERAMENT lBONE VOID FILLER and Gentamicin Eluting CERAMENT lG for Prophylactic Use in Bone Tumor Patients
        • Table Cerament|G CERAMENT/G Bone Healing and Re-infection Prophylaxis
    • Calcitec, Inc. Company Overview
      • Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Corticell Product Status
        • Table Corticell Product Description
    • Citrics Biomedical, LLC (Inactive) Company Overview
      • Citrics Biomedical, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Citrics Biomedical, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table CitrOSponge Product Status
        • Table CitrOSponge Product Description
    • curasan AG Company Overview
      • curasan AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table curasan AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cerasorb Classic Ortho Product Status
        • Table Cerasorb Classic Ortho Product Description
        • Table Cerasorb M Ortho Product Status
        • Table Cerasorb M Ortho Product Description
        • Table Cerasorb Ortho Foam Product Status
        • Table Cerasorb Ortho Foam Product Description
        • Table Cerasorb Paste Product Status
        • Table Cerasorb Paste Product Description
    • DSM Biomedical BV Company Overview
      • DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Structural Synthetic Bone Graft Product Status
        • Table Structural Synthetic Bone Graft Product Description
    • Graftys SA Company Overview
      • Graftys SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Graftys SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table GRFT-M04 Product Status
        • Table GRFT-M04 Product Description
        • Table GRFT-R02 Product Status
        • Table GRFT-R02 Product Description
        • Table Product Status
        • Table Product Description
        • Table Intelligent Bone Substitute Infection Product Status
        • Table Intelligent Bone Substitute Infection Product Description
        • Table Intelligent Bone Substitute Post-Operative Intraosseous Pain Product Status
        • Table Intelligent Bone Substitute Post-Operative Intraosseous Pain Product Description
    • Inion Oy Company Overview
      • Inion Oy Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inion Oy Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodegradable Cervical Interbody Fusion Block Product Status
        • Table Biodegradable Cervical Interbody Fusion Block Product Description
    • Innovia LLC Company Overview
      • Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vertebral Disc Filler Product Status
        • Table Vertebral Disc Filler Product Description
    • King's College London Company Overview
      • King's College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table King's College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bone Graft Substitute Product Status
        • Table Bone Graft Substitute Product Description
    • Kuros Biosciences AG Company Overview
      • Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table MagnetOs Putty Orthopedic And Dental Product Status
        • Table MagnetOs Putty Orthopedic And Dental Product Description
        • Table MagnetOs Putty Spinal Fusion Product Status
        • Table MagnetOs Putty Spinal Fusion Product Description
    • Maxigen Biotech Inc Company Overview
      • Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Product Status
        • Table Product Description
        • Table MaxiCure Product Status
        • Table MaxiCure Product Description
        • Table MaxiSetin Product Status
        • Table MaxiSetin Product Description
    • Meta Biomed Co Ltd Company Overview
      • Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bone Filler Product Status
        • Table Bone Filler Product Description
    • N2 Biomedical Company Overview
      • N2 Biomedical Pipeline Products & Ongoing Clinical Trials Overview
        • Table N2 Biomedical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antimicrobial Biodegradable Bone Graft Product Status
        • Table Antimicrobial Biodegradable Bone Graft Product Description
    • National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview
      • National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products & Ongoing Clinical Trials Overview
        • Table National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products &
        • Table Composite Bone Graft Substitute Product Status
        • Table Composite Bone Graft Substitute Product Description
    • NovaBone Products LLC Company Overview
      • NovaBone Products LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table NovaBone Products LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioengineered Resorbable Bone Graft Orthopedic Product Status
        • Table Bioengineered Resorbable Bone Graft Orthopedic Product Description
    • NuVasive Inc Company Overview
      • NuVasive Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NuVasive Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AttraX Putty Product Status
        • Table AttraX Putty Product Description
        • Table NuVasive Inc Ongoing Clinical Trials Overview
        • Table AttraX Putty A Randomized Controlled Trial of AttraX Putty vs. Autograft in Instrumented Posterolateral Spinal Fusion
    • Orthocell Ltd Company Overview
      • Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table CelGro Collagen Scaffold Bone Void Filling Product Status
        • Table CelGro Collagen Scaffold Bone Void Filling Product Description
    • Orthogem Company Overview
      • Orthogem Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orthogem Pipeline Products & Ongoing Clinical Trials Overview
        • Table TriPore Putty Product Status
        • Table TriPore Putty Product Description
    • Orthogen LLC Company Overview
      • Orthogen LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orthogen LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table DentoGen-CR Product Status
        • Table DentoGen-CR Product Description
    • PolyPid Ltd Company Overview
      • PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table BonyPid-1000 Product Status
        • Table BonyPid-1000 Product Description
        • Table PolyPid Ltd Ongoing Clinical Trials Overview
        • Table BonyPid-1000 Safety and Performance of BonyPid-1000 in the Treatment of Gustilo IIIA and IIIB Tibial Open Fractures
    • Promimic AB Company Overview
      • Promimic AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Promimic AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table HAnano Bone Product Status
        • Table HAnano Bone Product Description
    • RepRegen Ltd. (Inactive) Company Overview
      • RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bone Graft Substitute Load Bearing Product Status
        • Table Bone Graft Substitute Load Bearing Product Description
        • Table StronBone-P Product Status
        • Table StronBone-P Product Description
    • Revivicor Inc Company Overview
      • Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tendon ACL Repair Product Status
        • Table Tendon ACL Repair Product Description
    • San Raffaele hospital Company Overview
      • San Raffaele hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table San Raffaele hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tissue Repair Composite Scaffold Product Status
        • Table Tissue Repair Composite Scaffold Product Description
    • Scil Technology GmbH Company Overview
      • Scil Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Scil Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table ST01 Bone Graft Substitute Material Product Status
        • Table ST01 Bone Graft Substitute Material Product Description
    • SIRAKOSS Ltd Company Overview
      • SIRAKOSS Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table SIRAKOSS Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MaxSi Graft Granules Product Status
        • Table MaxSi Graft Granules Product Description
        • Table MaxSi Graft Putty Product Status
        • Table MaxSi Graft Putty Product Description
    • Sofregen Medical Inc Company Overview
      • Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SeriACL Scaffold Product Status
        • Table SeriACL Scaffold Product Description
        • Table SeriCuff Scaffold Product Status
        • Table SeriCuff Scaffold Product Description
    • Soft Tissue Regeneration Inc Company Overview
      • Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Soft Tissue Regeneration Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table L-C Ligament Product Status
        • Table L-C Ligament Product Description
    • Soteira Inc Company Overview
      • Soteira Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Soteira Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanotechnology Bone Biomaterial Spinal Repair Product Status
        • Table Nanotechnology Bone Biomaterial Spinal Repair Product Description
    • Trinity College Dublin Company Overview
      • Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Eluting Porous Scaffold Product Status
        • Table Drug Eluting Porous Scaffold Product Description
    • University of California San Diego Company Overview
      • University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table Synthetic Bone Graft Product Status
        • Table Synthetic Bone Graft Product Description
    • University of Edinburgh Company Overview
      • University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shapeable Foam Bone Repair Product Status
        • Table Shapeable Foam Bone Repair Product Description
    • University of Nottingham's School Of Pharmacy Company Overview
      • University of Nottingham's School Of Pharmacy Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Nottingham's School Of Pharmacy Pipeline Products & Ongoing Clinical Trials Overview
        • Table Product Status
        • Table Product Description
    • Wound Management Technologies Inc Company Overview
      • Wound Management Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Wound Management Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bone Void Filler Product Status
        • Table Bone Void Filler Product Description
    • Wright Medical Group NV Company Overview
      • Wright Medical Group NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Wright Medical Group NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Augment Chronic Tendinopathy Product Status
        • Table Augment Chronic Tendinopathy Product Description
        • Table Product Status
        • Table Product Description
        • Table Augment Rotator Cuff Graft Product Status
        • Table Augment Rotator Cuff Graft Product Description
  • Synthetic Bone Graft SubstitutesRecent Developments
    • Aug 29, 2017: Globus Medical Appoints David M. Demski as CEO
    • Aug 29, 2017: NuVasive Announces World-Class Innovation Center At San Diego Headquarters
    • Aug 28, 2017: Kuros receives clearance for MagnetOs Putty for commercialization in the United States and files the product for CE marking in Europe
    • Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs
    • Aug 25, 2017: Sr – HTGahnite Done Substitute Project Update
    • Aug 22, 2017: Medtronic Reports First Quarter Financial Results
    • Aug 17, 2017: BONESUPPORT Holding: Interim Report January June 2017
    • Aug 15, 2017: Nuvasive Appoints Rajesh J Asorpota as Chief Financial Officer
    • Aug 14, 2017: Governor McAuliffe Announces LifeNet Health to Invest $12.25 million, Create 321 New Jobs in City of Virginia Beach
    • Aug 14, 2017: aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017Berlin, 14 August 2017
    • Aug 10, 2017: Alphatec Holdings Reports Second Quarter 2017 Financial Results
    • Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker
    • Aug 08, 2017: RTI Surgical Announces 2017 Second Quarter Results
    • Aug 02, 2017: Globus Medical Reports Second Quarter 2017 Results
    • Aug 02, 2017: Wright Medical Group Reports 2017 Second Quarter Financial Results
    • Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd
    • Jul 27, 2017: Hoya Reports First Quarter Financial Results
    • Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results
    • Jul 27, 2017: Stryker reports second quarter 2017 results
    • Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President
    • Jul 27, 2017: NuVasive Announces New Organizational Structure To Drive Growth And Profitability Goals
    • Jul 27, 2017: NuVasive Reports Second Quarter 2017 Financial Results
    • Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020
    • Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results
    • Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results
    • Jul 20, 2017: Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter
    • Jul 18, 2017: Spineway: Confirmed growth Revenue for the first half of 2017: €6M (+146%)
    • Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board
    • Jul 11, 2017: Zimmer Biomet Announces Leadership Transition
    • Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results
    • Jul 11, 2017: Medicrea Reports First Half 2017 Sales
    • Jun 15, 2017: aap: Supervisory Board extends both Management Board members' contracts prematurely until the end of 2020
    • Jun 14, 2017: Spineway Records a New $1M Order in the USA
    • Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter
    • Jun 06, 2017: Kuros Biosciences submits MagnetOs Putty for US FDA Clearance
    • Jun 01, 2017: NuVasive Appoints Skip Kiil As Executive Vice President, International
    • May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress
    • May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
    • May 24, 2017: NovaBone Announces Irrigation Resistant Products with Carriers that have Synergistic Effect in Bone Formation
    • May 24, 2017: NovaBone Provides Update on NovaBone IRM MacroPO
    • May 22, 2017: BONESUPPORT Announces First Patient Enrolled in FORTIFY Trial With -eluting Bone Graft Substitute
    • May 22, 2017: NuVasive Announces Educational Initiatives In Support Of Spine's Fastest Growing Spinal Deformity Portfolio
    • May 17, 2017: Wound Management Issues 2017 10Q and Hires New Strategic Marketing Director
    • May 11, 2017: Hoya Reports Fourth Quarter and Full-Year Financial Results
    • May 11, 2017: Alphatec Reports First Quarter 2017 Financial Results
    • May 03, 2017: Globus Medical Reports First Quarter 2017 Results
    • May 03, 2017: Wright Medical Group Reports 2017 First Quarter Financial Results
    • May 03, 2017: Anika Reports First Quarter 2017 Financial Results
    • Apr 28, 2017: Lennart Johansson to Join BONESUPPORT Board of Directors
    • Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results
    • Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results
    • Apr 27, 2017: Q1 2017 Sales Up 32% Over Q1 2016, for Wound Management Technologies
    • Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results
    • Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017
    • Apr 26, 2017: Spineway: 2016 Annual results
    • Apr 25, 2017: Stryker reports first quarter 2017 results
    • Apr 25, 2017: NuVasive Announces First Quarter 2017 Financial Results
    • Apr 13, 2017: Medicrea Releases First Quarter Sales For 2017
    • Apr 11, 2017: BONESUPPORT Appoints Michael Diefenbeck as Chief Medical Officer
    • Mar 31, 2017: aap: Annual financial statements for 2016: aap with fundamental progress in strategy implementation – Transformation to a pure player in trauma completed
    • Mar 30, 2017: Medicrea Announces 2016 Annual Results
    • Mar 24, 2017: Alphatec Completes its Senior Leadership Team with Appointment of Brian Snider, Executive Vice President, Strategic Marketing and Product Development
    • Mar 15, 2017: Alphatec Holdings Announces Fourth Quarter and Full Year 2016 Financial Results
    • Mar 09, 2017: PolyPid Announces Positive Interim Data from Company's Confirmatory Clinical Trial for BonyPid-1000 Antibiotic Eluting Bone Substitute
    • Mar 08, 2017: Wound Management announces appointment of John Siedhoff as Chairman
    • Feb 28, 2017: Synergy Biomedical Receives CE Mark for BIOSPHERE PUTTY
    • Feb 27, 2017: Globus Medical Reports Full Year and Fourth Quarter 2016 Results
    • Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth
    • Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance
    • Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
    • Feb 21, 2017: Wright Medical Group Reports 2016 Fourth Quarter and Full-Year Financial Results and Provides 2017 Guidance
    • Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results
    • Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011
    • Feb 14, 2017: Alphatec Spine Announces Appointment of David H. Mowry to its Board of Directors
    • Feb 14, 2017: Wound Management Technologies Announces Record Quarterly and Annual Sales Ending December 31, 2016 Up 147% over Q4 2015, and 63% over 2015
    • Feb 10, 2017: Allegra Orthopaedics Provides Update on Sr-HT-Gahnite Bone Substitute
    • Feb 09, 2017: NuVasive Reports Fourth Quarter And Full Year 2016 Financial Results
    • Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board
    • Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
    • Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results
    • Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results
    • Jan 31, 2017: Hoya Announces Third Quarter Financial Results
    • Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer
    • Jan 26, 2017: Calmare Theraeutics Board of Directors Changes
    • Jan 24, 2017: Stryker reports 2016 results and 2017 outlook
    • Jan 18, 2017: Karolinska Development portfolio company Promimic appoints Magnus Larsson as new CEO and launches US sales operation
    • Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition
    • Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board
    • Jan 16, 2017: SurgaColl Technologies: Board Announcement Appointment of CEO
    • Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters
    • Jan 12, 2017: Medicrea Releases Annual Sales for 2016
    • Jan 10, 2017: Stryker provides 2016 preliminary net sales results
    • Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results
    • Jan 10, 2017: Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results
    • Jan 09, 2017: NuVasive Announces Select Preliminary Unaudited Full Year 2016 Financial Results and 2017 Outlook
    • Jan 06, 2017: BONESUPPORT CEO Richard Davies to present at Medtech Showcase 2017
    • Jan 03, 2017: Calmare Therapeutics Reports Third Quarter 2016 Results
    • Dec 21, 2016: Bjorn Westburg to join BONESUPPORT as Chief Financial Officer
    • Dec 16, 2016: BONESUPPORT Confirms Election of Dr.Hakan Bjorklund as Chaiman of the Board
    • Dec 14, 2016: RTI Surgical Names Robert P. Jordheim Interim CEO
    • Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection
    • Dec 12, 2016: Alphatec Holdings appoints new CEO
    • Dec 12, 2016: Alphatec Holdings Announces Board and Executive Leadership Changes
    • Dec 08, 2016: Wound Management Technologies Welcomes J. Michael Carmena as its New CFO
    • Dec 07, 2016: curasan receives market clearance for orthopedic product in the strategically important US market
    • Dec 05, 2016: Integra LifeSciences announces management changes
    • Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments
    • Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
    • Nov 22, 2016: Collagen Matrix Names Oystein Valberg as Chief Financial Officer
    • Nov 17, 2016: New UK Business Manager Appointed At JRI Orthopaedics
    • Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
    • Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
    • Nov 10, 2016: Curasan Continues Dynamic Growth in the Third Quarter
    • Nov 09, 2016: Alphatec Holdings Announces Third Quarter 2016 Revenue and Financial Results
    • Nov 08, 2016: Globus Medical Reports Third Quarter 2016 Results
    • Nov 07, 2016: BONESUPPORT Announces Key Corporate Appointment To Drive Growth In North America
    • Nov 03, 2016: DSM Q3 2016 Results
    • Nov 02, 2016: Wright Medical Group Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance
    • Nov 01, 2016: Wound Management Technologies Reports Preliminary Financial Results For Q3 2016 Sales Up 56% over Q3 2015, and 2016 YTD Sales Up 41% over 2015 YTD Sales
    • Oct 31, 2016: Allegra Orthopaedics Provides Update on Sr-HT-Gahnite Bone Substitute
    • Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results
    • Oct 28, 2016: Hoya Reports Second Quarter Results
    • Oct 27, 2016: Karolinska Development Portfolio Company Promimic Appoints New Chairman and Directors to its Board
    • Oct 27, 2016: Stryker reports third quarter 2016 results
    • Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results
    • Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results
    • Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results
    • Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016
    • Oct 25, 2016: NuVasive Reports Third Quarter 2016 Financial Results
    • Oct 06, 2016: Medicrea Announces 2016 Third-Quarter Sales
    • Oct 05, 2016: Alphatec Holdings Announces Company Updates
    • Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report